Therefore, the aim of this study was to generate NK cells by invitro differentiation of human derived UCB CD34 cells and to expand these NK cells in vitro using the best available methodology and finally test the cytotoxic potential of these NK cells against different cancer cell lines. The gene discussed is CD34; the disease is cancer.